Spin-off news
Here you can find news from MPG spin-off companies.
Alnylam
| Spin-off News
Alnylam Reports Positive Topline Results from Phase 2 Study of Investigational Cemdisiran for the Treatment of IgA Nephropathy
Dewpoint Therapeutics
| Spin-off News
Dewpoint Therapeutics Granted Foundational Platform Technology Patent by US Patent Office
Alnylam
| Spin-off News
Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1
Proteros
| Spin-off News
Proteros expands oncology collaboration and license agreement with Astrazeneca
MorphoSys
| Spin-off News
MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with r/r DLBCL